(firstQuint)A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199.

 This is a Phase 1 study designed to assess how the body processes the study drug ABT-199 when taken alone and in combination with rifampin and to assess the safety of ABT-199 in combination with rifampin.

 Subjects may enroll in a separate extension study to continue receiving ABT-199 after completion of this study.

.

 A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199@highlight

This is an open-label multicenter, study to assess the pharmacokinetic interaction of rifampin with ABT-199 in up to 12 subjects with relapsed or refractory non-Hodgkin's lymphoma.

